Dr. Ciafaloni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-4568Fax+1 585-273-1254
Education & Training
- Duke University HospitalResidency, Neurology, 1996 - 1998
- University of Milan Faculty of MedicineClass of 1989
- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology)
Certifications & Licensure
- NY State Medical License 2002 - 2026
- NC State Medical License 1999 - 2003
- VA State Medical License 2001 - 2002
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Characteristics of Andersen-Tawil Syndrome Start of enrollment: 2007 Nov 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 117 citationsLong-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui-Chien Kuo
The Lancet. Neurology. 2019-03-01 - 161 citationsDelayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)Emma Ciafaloni, Deborah J. Fox, Shree Pandya, Christina Westfield, Soman Puzhankara
The Journal of Pediatrics. 2009-09-01 - 51 citationsEffect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.Michela Guglieri, Kate Bushby, Michael P McDermott, Kimberly A Hart, Rabi Tawil
JAMA. 2022-04-19
Journal Articles
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsEmma Ciafaloni, Christopher Cunniff, AAP News
Authored Content
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsJuly 2018
Press Mentions
- Recommendations for Clinical Trial Design in Duchenne Muscular Dystrophy: Emma Ciafaloni, MDOctober 2nd, 2022
- COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular DisordersMay 21st, 2020
- Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular DystrophyAugust 15th, 2019
- Join now to see all
Grant Support
- Trial To Assess The Efficacy &Safety Of MMF In Subjects With Myasthenia GravisNational Center For Research Resources2005
- Causes Of Excessive Sleepiness In Myotonic DystrophyNational Center For Research Resources2004–2005
- A Clinical Trial Of Cellcept In The Treatment Of Myasthenia GravisNational Center For Research Resources2004–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: